Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
34 studies found for:    Open Studies | "Carcinoma, Basal Cell"
Show Display Options
Rank Status Study
1 Recruiting To Assess The Efficacy And Safety Of Vismodegib And Radiotherapy In Advanced Basal Cell Carcinoma
Condition: Carcinoma, Basal Cell
Interventions: Drug: Vismodegib;   Radiation: Radiotherapy
2 Recruiting VISmodegib for ORbital and Periocular Basal Cell Carcinoma
Condition: Carcinoma, Basal Cell
Intervention: Drug: Vismodegib
3 Recruiting Reflectance Confocal Microscopy in Basal Cell Carcinoma
Condition: Carcinoma, Basal Cell
Interventions: Device: Reflectance confocal microscopy;   Procedure: Punch biopsy;   Procedure: Surgical excision
4 Recruiting Topical Itraconazole in the Treatment of Basal Cell Carcinoma
Condition: Basal Cell Carcinoma
Intervention: Drug: Itraconazole
5 Not yet recruiting The Role of Melanocyte in Basal Cell Carcinoma
Condition: Basal Cell Carcinoma
Intervention: Other: No intervention
6 Recruiting Vismodegib on Locally Advanced and Metastatic Basal Cell Carcinoma Under Real World Conditions
Condition: Metastatic Basal Cell Carcinoma
Intervention:
7 Recruiting Clinical Trial of Patidegib Gel 2%, 4%, and Vehicle Applied Once or Twice Daily to Decrease the Size of Sporadic Nodular Basal Cell Carcinomas
Condition: Basal Cell Carcinomas
Interventions: Drug: patidegib gel 2% - cohort 1;   Drug: patidegib gel 4% - cohort 2;   Drug: Vehicle - cohort 1;   Drug: patidegib gel 2% - cohort 3;   Drug: patidegib gel 4% - cohort 4;   Drug: vehicle - cohort 2;   Drug: Vehicle - cohort 3;   Drug: Vehicle - cohort 4
8 Recruiting Surgery Versus Combined Treatment With Curettage and Imiquimod for Nodular Basal Cell Carcinoma
Condition: Nodular Basal Cell Carcinoma
Interventions: Drug: Imiquimod 5% cream with prior curettage;   Procedure: Standard surgical excision
9 Recruiting Photodynamic Therapy and Vismodegib for Multiple Basal Cell Carcinomas
Condition: Basal Cell Carcinoma
Intervention: Drug: Vismodegib
10 Recruiting An Observational Study of the Effectiveness and Safety of Erivedge® in Patients With Advanced Basal Cell Carcinoma
Condition: Basal Cell Carcinoma
Intervention: Drug: Erivedge®
11 Not yet recruiting Arsenic Trioxide and Itraconazole in Treating Patients With Advanced Basal Cell Cancer
Condition: Skin Basal Cell Carcinoma
Interventions: Drug: Arsenic Trioxide;   Drug: Itraconazole;   Other: Laboratory Biomarker Analysis
12 Recruiting Topical Itraconazole in Treating Patients With Basal Cell Cancer
Condition: Skin Basal Cell Carcinoma
Interventions: Drug: Itraconazole;   Other: Placebo
13 Recruiting Pembrolizumab With or Without Vismodegib in Treating Metastatic or Unresectable Basal Cell Skin Cancer
Condition: Skin Basal Cell Carcinoma
Interventions: Other: Laboratory Biomarker Analysis;   Biological: Pembrolizumab;   Drug: Vismodegib
14 Recruiting Effectiveness of Narrow Margins in Patients With Low-Risk Basal Cell Carcinoma Undergoing Surgery
Condition: Skin Basal Cell Carcinoma
Intervention: Procedure: Therapeutic Conventional Surgery
15 Recruiting A Study of the Efficacy and Safety of ASN-002 in Adult Patients With Low-risk Nodular Basal Cell Carcinoma
Conditions: Carcinoma, Basal Cell,;   Skin Neoplasm
Intervention: Biological: ASN-002
16 Recruiting Observational Study to Determine the Effectiveness and Safety of Vismodegib in Patients With Locally Advanced Basal Cell Carcinoma (laBCC)
Condition: Locally Advanced Basal Cell Carcinoma
Intervention: Drug: Vismodegib
17 Recruiting An Observational Study to Determine the Clinical Cure Rate of Therapeutic up Front Shave Removal of Basal Cell Carcinoma of the Skin With Long Term Follow up to Evaluate Recurrence
Condition: Basal Cell Carcinoma
Intervention: Procedure: Deep shave removal using a blue surgical blade
18 Not yet recruiting Early Detection of Skin Cancer With Sensor Technology
Condition: Carcinoma, Basal Cell
Intervention: Device: WR-22 model microwave sensor
19 Recruiting Open-label Trial of SUBA™-Itraconazole (SUBA-Cap) in Subjects With Basal Cell Carcinoma Nevus Syndrome (BCCNS)
Condition: Basal Cell Carcinoma in Basal Cell Nevus Syndrome
Intervention: Drug: SUBA-Itraconazole
20 Recruiting Study Evaluating the Efficacy of Oral Vismodegib in Various Histologic Subtypes
Condition: Basal Cell Carcinoma
Intervention: Drug: vismodegib (150 mg PO daily)

   Previous Page Studies Shown (1-20) Next Page (21-34) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.